These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 981634)

  • 21. Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck.
    Herchenhorn D; Dias FL; Viegas CM; Federico MH; Araújo CM; Small I; Bezerra M; Fontão K; Knust RE; Ferreira CG; Martins RG
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):696-702. PubMed ID: 20421154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
    Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
    Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer.
    Cummings B; Keane T; Pintilie M; Warde P; Waldron J; Payne D; Liu FF; Bissett R; McLean M; Gullane P; O'Sullivan B
    Radiother Oncol; 2007 Oct; 85(1):7-16. PubMed ID: 17920715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme.
    Chen AM; Vaughan A; Narayan S; Vijayakumar S
    Head Neck; 2008 Dec; 30(12):1586-91. PubMed ID: 18798313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial.
    Haffty BG; Wilson LD; Son YH; Cho EI; Papac RJ; Fischer DB; Rockwell S; Sartorelli AC; Ross DA; Sasaki CT; Fischer JJ
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):119-28. PubMed ID: 15629602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity.
    Peñagarícano JA; Moros EG; Ratanatharathorn V; Yan Y; Corry P
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1369-75. PubMed ID: 19625138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.
    Suwinski R; Jaworska M; Nikiel B; Grzegorz W; Bankowska-Wozniak M; Wojciech M; Krzysztof S; Dariusz L
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):438-46. PubMed ID: 19733016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
    Tahara M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
    Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
    Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer.
    Hartley A; Sanghera P; Kazi W; Mehanna H; McConkey C; Glaholm J; Fowler J
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):29-33. PubMed ID: 20829006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Very accelerated radiation therapy: preliminary results in locally unresectable head and neck carcinomas.
    Bourhis J; Fortin A; Dupuis O; Domenge C; Lusinchi A; Marandas P; Schwaab G; Armand JP; Luboinski B; Malaise E
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):747-52. PubMed ID: 7790261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.
    Lee DJ; Cosmatos D; Marcial VA; Fu KK; Rotman M; Cooper JS; Ortiz HG; Beitler JJ; Abrams RA; Curran WJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):567-76. PubMed ID: 7790241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with Mitomycin C and Bleomycin.
    Zakotnik B; Budihna M; Smid L; Soba E; Strojan P; Fajdiga I; Zargi M; Oblak I; Lesnicar H
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):685-90. PubMed ID: 17197122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.
    Garden AS; Harris J; Vokes EE; Forastiere AA; Ridge JA; Jones C; Horwitz EM; Glisson BS; Nabell L; Cooper JS; Demas W; Gore E
    J Clin Oncol; 2004 Jul; 22(14):2856-64. PubMed ID: 15254053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of conventional versus high fractional dose radiation therapy in the treatment of advanced head and neck cancer.
    Weissberg JB; Son YH; Percarpio B; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):179-85. PubMed ID: 6806218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutron therapy for head and neck cancer: I. A final report of the MDAH-TAMVEC pilot studies.
    Maor MH; Hussey DH; Barkely HT; Peters LJ
    Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1255-60. PubMed ID: 6309710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twice-daily fractionation schemes for advanced head and neck cancer.
    Meoz RT; Fletcher GH; Peters LJ; Barkley HT; Thames HD
    Int J Radiat Oncol Biol Phys; 1984 Jun; 10(6):831-6. PubMed ID: 6735767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary results in advanced head and neck cancer with radiotherapy by multiple fractions a day.
    Gonzalez DG; Breur K; vd Schueren E
    Clin Radiol; 1980 Jul; 31(4):417-21. PubMed ID: 7418342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.